These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1688507)

  • 1. Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second-look resection.
    Tang ZY; Liu KD; Bao YM; Lu JZ; Yu YQ; Ma ZC; Zhou XD; Yang R; Gan YH; Lin ZY
    Cancer; 1990 Jan; 65(2):211-5. PubMed ID: 1688507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multimodality treatment and two-stage resection for unresectable hepatocellular carcinoma--experimental and clinical studies].
    Tang ZY
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):2-5. PubMed ID: 2163821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma (HCC)].
    Li KD
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 14(6):430-2. PubMed ID: 1338985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary result of mixed bacterial vaccine as adjuvant treatment of hepatocellular carcinoma.
    Tang ZY; Zhou HY; Zhao G; Chai LM; Zhou M; Lu JZ; Liu KD; Havas HF; Nauts HC
    Med Oncol Tumor Pharmacother; 1991; 8(1):23-8. PubMed ID: 1645825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin. Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion.
    Fan Z; Tang Z; Liu K; Zhou D; Lu J; Yuan A; Zhao H
    J Cancer Res Clin Oncol; 1992; 118(5):371-6. PubMed ID: 1316355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunotherapy for hepatocellular carcinoma (HCC) using 131I-anti HCC isoferritin IgG: preliminary results of experimental and clinical studies.
    Liu KD; Tang ZY; Bao YM; Lu JZ; Qian F; Yuan AN; Zhao HY
    Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):319-23. PubMed ID: 2537805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131I-anti-HCC mAb. Phase I/II clinical trials.
    Zeng ZC; Tang ZY; Liu KD; Lu JZ; Xie H; Yao Z
    J Cancer Res Clin Oncol; 1998; 124(5):275-80. PubMed ID: 9645459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioimmunotherapy combined with chemotherapy and immunotherapy for nude mice bearing human hepatocellular carcinoma].
    Bao YM
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):245-7. PubMed ID: 2625102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunotherapy for unresectable hepatocellular carcinoma using 131I-Hepama-1 mAb: preliminary results.
    Zeng ZC; Tang ZY; Xie H; Liu KD; Lu JZ; Chai XJ; Wang GF; Yao Z; Qian JM
    J Cancer Res Clin Oncol; 1993; 119(5):257-9. PubMed ID: 8382704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The experimental study of anti-human AFP variant McAb in radioimmuno-detection and radioimmuno-therapy of human hepatocellular carcinoma model in nude mice].
    Liu Y; Wu MC; Qian GX
    Zhonghua Wai Ke Za Zhi; 1994 Nov; 32(11):650-3. PubMed ID: 7539734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
    Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
    Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable low dose rate irradiation (131I-anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinoma.
    Stillwagon GB; Order SE; Haulk T; Herpst J; Ettinger DS; Fishman EK; Klein JL; Leichner PK
    Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1601-5. PubMed ID: 1657845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131I-labeled Hepama-1 mAb. Preliminary results and discussion.
    Zeng ZC; Tang ZY; Liu KD; Lu JZ; Cai XJ; Xie H
    Cancer Immunol Immunother; 1994 Nov; 39(5):332-6. PubMed ID: 7987865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical trial of targeted therapy using 131I-Hepama-1 mAb in patients with hepatocellular carcinoma.
    Chen S; Li B; Xie H; Xu L; Niu G; Fan K; Fan Q
    Cancer Biother Radiopharm; 2004 Oct; 19(5):589-600. PubMed ID: 15650451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival for hepatocellular cancer with combination surgery and multimodality treatment.
    Sitzmann JV; Abrams R
    Ann Surg; 1993 Feb; 217(2):149-54. PubMed ID: 8382468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on small hepatocellular carcinoma and its extension.
    Tang Z; Yu Y; Zhou X; Yang B; Lin Z; Lu J; Ma Z; Liu K; Ye S; Wu Z
    Chin Med Sci J; 1997 Sep; 12(3):133-8. PubMed ID: 11360621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of radio-immunochemotherapy-using antiferritin antibody combined with anthracycline drugs on hepatocellular carcinoma cell].
    Une Y; Sato Y; Alam S; Nagabuchi E; Hata Y; Uchino J
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):161-3. PubMed ID: 8380685
    [No Abstract]   [Full Text] [Related]  

  • 18. Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma.
    Tang ZY; Zhou XD; Ma ZC; Wu ZQ; Fan J; Qin LX; Yu Y
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):495-8. PubMed ID: 15567731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Targeting study of human hepatocellular carcinoma (HCC) using human HCC model in nude mice].
    Liu KD
    Zhonghua Zhong Liu Za Zhi; 1988 Nov; 10(6):414-6. PubMed ID: 2855054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
    Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK
    J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.